Evidence map›Paper›PMID 42237480›Full record

ArticleNeuropsychopharmacology reports2026

Sex Difference in Effect of the OPRM1 Gene A118G (rs1799971) Single-Nucleotide Polymorphism on the Requirement for Postoperative Fentanyl in Japanese Patients Who Underwent Laparoscopic-Assisted Colectomy.

Hideyuki Nakagawa, Daisuke Nishizawa, Tsutomu Mieda, Miki Tsujita, Shinya Kasai, Junko Hasegawa, Kyoko Nakayama, Yuko Ebata, Akira Kitamura, Masakazu Hayashida and 1 more

Abstract read
In one paragraph

Article in Neuropsychopharmacology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hideyuki NakagawaDepartment of Anesthesiology, Saitama Medical University International Medical Center, Hidaka-Shi, Saitama, Japan.
Daisuke NishizawaAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0001-8286-4651
Tsutomu MiedaDepartment of Anesthesiology, Saitama Medical University Hospital, Saitama, Japan.
Miki TsujitaDepartment of Anesthesiology, Saitama Medical University International Medical Center, Hidaka-Shi, Saitama, Japan.
Shinya KasaiAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0002-9955-629X
Junko HasegawaAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, Japan.
Kyoko NakayamaAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, Japan.
Yuko EbataAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, Japan.
Akira KitamuraDepartment of Anesthesiology, Saitama Medical University International Medical Center, Hidaka-Shi, Saitama, Japan.
Masakazu HayashidaDepartment of Anesthesiology, Saitama Medical University International Medical Center, Hidaka-Shi, Saitama, Japan.ORCID https://orcid.org/0000-0002-3598-2281
Kazutaka IkedaAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0001-8342-0278

Funding

Asahi Kasei Pharma Open InnovationJapan Agency for Medical Research and Development JP19dk0307071Japan Agency for Medical Research and Development JP19ek0610011Japan Research Foundation for Clinical PharmacologyMinistry of Health, Labour and Welfare H26-Kakushintekigan-ippan-060Multilayered Stress Diseases JPMXP1323015483Smoking Research Foundationthe Japan Society for the Promotion of Science, KAKENHI 17H04324the Japan Society for the Promotion of Science, KAKENHI 17K08970the Japan Society for the Promotion of Science, KAKENHI 18K08829the Japan Society for the Promotion of Science, KAKENHI 20K09259the Japan Society for the Promotion of Science, KAKENHI 21H03028the Japan Society for the Promotion of Science, KAKENHI 22790518the Japan Society for the Promotion of Science, KAKENHI 23390377the Japan Society for the Promotion of Science, KAKENHI 24790544the Japan Society for the Promotion of Science, KAKENHI 26293347the Japan Society for the Promotion of Science, KAKENHI JP22H04922
6 · The paper itself

Abstract

backgroundThe A118G (rs1799971) single-nucleotide polymorphism (SNP) of the OPRM1 gene, which encodes the μ-opioid receptor, reportedly affects postoperative morphine requirements but not fentanyl requirements. The present study investigated whether this SNP influences postoperative fentanyl requirements after laparoscopic-assisted colectomy (LAC).

methodsWe examined 350 Japanese patients who underwent LAC for colorectal cancer. Postoperative pain was managed with an initial intravenous bolus dose of fentanyl, followed by intravenous fentanyl patient-controlled analgesia (PCA). The primary endpoint was the 12-h postoperative fentanyl requirement, defined as the sum of the initial bolus dose and PCA consumption at 12 h postoperatively, which was normalized to body weight. Genotypes of the A118G SNP were obtained from our previous whole-genome genotyping. Associations between genotypes and pain-related phenotypes were analyzed using the Jonckheere-Terpstra test, followed by the Mann-Whitney U test. Values of p < 0.05 were considered statistically significant.

resultsIn the total cohort, the 12-h postoperative fentanyl requirement was significantly higher in GG homozygotes than in AA homozygotes (p = 0.022). Among 217 males, it was higher in GG homozygotes than in both AA homozygotes (p = 0.006) and AG heterozygotes (p = 0.038). In contrast, among 133 females, this endpoint was unaffected by the genotype of the A118G SNP.

conclusionIn patients who underwent LAC, the OPRM1 A118G SNP significantly influenced postoperative fentanyl requirements in the total cohort, but this effect was observed only in males. These findings indicate a sex-dependent influence of the A118G SNP on postoperative fentanyl requirements in Japanese patients who underwent LAC.

trial registrationUniversity Hospital Medical Information Network Clinical Trials Registry (Trial ID: UMIN000003814).

Indexed as

Analgesics, OpioidColectomyFentanylLaparoscopyPostoperative PainReceptors, Opioid, muSex CharacteristicsAgedAnalgesia, Patient-ControlledColorectal NeoplasmsEast Asian PeopleFemaleGenotypeHumansJapanMaleAnalgesics, OpioidFentanylOPRM1 protein, humanReceptors, Opioid, mufentanylOPRM1postoperative painsexsingle‐nucleotide polymorphism

Identifiers

PMID42237480
PMCPMC13581092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.